VDI Technologies

What VDI Technologies does

VDI Technologies s.r.o. is a Brno, Czech Republic-based medical device company founded in 2022 that develops and commercializes ultra-high-frequency ECG (UHF-ECG) systems for non-invasive ventricular dyssynchrony imaging. Its core technology captures ECG signals with a 2 kHz bandwidth sampled at 5 kHz, enabling analysis of high-frequency components in the 150-1000 Hz band that are invisible to standard ECG systems limited to 100 Hz. The platform consists of the VDIAQ Acquisition Unit hardware amplifier, VDI Vision real-time mapping software, and VDI DeepView post-processing software, sold as integrated system configurations (VDI Cart, VDI Laptop, VDI Portable) priced by quote to hospitals and research institutions. The company holds CE Mark certification under EU MDR (2025) and ISO 13485:2016 (2024), and its software was validated on a database of over 10,000 recorded cases from 30+ research centers across 8 countries.

The company targets two primary customer segments: electrophysiology departments at hospitals and cardiac care centers (primary), and academic medical research institutions conducting cardiac electrophysiology research (secondary). Use cases include ventricular dyssynchrony imaging for cardiac resynchronization therapy optimization, conduction system pacing guidance, and pacemaker electrode placement support. The company employs a conference-driven enterprise field sales motion, with repeat presence at EHRA (2023-2025) and HRS (2023) and direct sales engagement in the EU and US markets.

VDI was spun out of the Czech Academy of Sciences' Institute of Scientific Instruments, where CTO and founder Pavel Jurak led the first UHF-ECG experiments in 2013. CEO Miroslav Navratil was appointed in April 2022. The company has been funded by a Cardion s.r.o.-led Series A (2023), a 4.95 million CZK CzechInvest Technological Incubation grant (2024), and a TAČR TREND project grant. Revenue is not publicly disclosed and the company employs 11-50 people. The underlying ECG-related intellectual property is licensed from a collaborative research agreement involving ICRC, Charles University, the Czech Academy of Sciences, Cardion, and VDI.

Name

VDI Technologies

Legal name

VDI Technologies s.r.o.

Website

https://vdimaging.com

Company type

Private

Founded year

2022

Operating status

Operating

Headcount range

11–50 employees

Short description

VDI Technologies is a Brno-based MedTech company that develops CE-marked ultra-high-frequency ECG (UHF-ECG) systems for non-invasive ventricular dyssynchrony imaging, serving electrophysiology departments at hospitals and academic cardiac research institutions in Europe and the US.

Ownership category

akta.pro rank

Product category

Cardiac Electrophysiology Equipment

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)

SIC

Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)

akta.pro industry

PRIMARYCRACAQAC

ECG/EKG & Heart Rhythm Monitors (Consumer)

Consumer Products & Retail/Consumer Electronics & Appliances Retail/Personal Health & Wellness Devices (Smart Scales, BP/ECG Monitors, Sleep Devices)

Keywords

• Cardiac electrophysiology equipment
• Ultra-high-frequency ECG
• Ventricular dyssynchrony imaging
• Cardiac resynchronization therapy
• Medical signal processing

Headquarters

HQ city

Brno

HQ country

Czechia

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Personnel, Supply Chain, Marketing or Sales, Operations, Others

Revenue model

1. UHF-ECG Hardware Systems: Sale of complete VDI UHF-ECG systems including VDIAQ acquisition unit, VDI Vision software, and accessories. Products are sold in multiple configurations: VDI Cart (dual-screen laptop), VDI Laptop, VDI Portable (laptop bag, backpack, or protect case).
2. Software Licenses and Modules: VDI Vision and VDI DeepView software modules provided with hardware systems for real-time analysis and post-processing of UHF-ECG data.
3. Professional Services: Expert consultations, certifications support, and clinical implementation services for healthcare providers adopting the technology.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

VDI Technologies develops and sells a CE-marked medical device system for non-invasive ventricular dyssynchrony mapping using ultra-high-frequency ECG (UHF-ECG) technology. The integrated platform combines a hardware ECG signal amplifier (VDIAQ) with proprietary software (VDI Vision, VDI DeepView) that captures and analyzes ECG signals up to 1,000 Hz—roughly ten times the bandwidth of standard ECG—to guide pacemaker, CRT, and conduction system pacing procedures.

Product overview

VDI Technologies offers a unified product ecosystem centered on its VDI UHF-ECG System, a CE-certified medical device platform for ventricular dyssynchrony imaging. The core system comprises the VDIAQ Acquisition Unit (hardware) working in conjunction with VDI Vision Software (software platform) to capture and analyze ultra-high-frequency ECG signals (150-1000 Hz). VDI DeepView serves as an add-on post-processing module for enhanced activation mapping. Products are available in three form factors: VDI Cart (dual-screen mobile cart for clinical settings), VDI Laptop (portable laptop configuration), and VDI Portable (travel-friendly bag/backpack/case options). The complete VDI UHF-ECG System delivers non-invasive cardiac diagnostics by processing signals far beyond standard ECG bandwidth to reveal ventricular activation patterns invisible to conventional technology.

Differentiator

Problem solved

Functional benefit

Brands

• VDI Vision: Comprehensive software for ultra-high-frequency ECG mapping with real-time visualization of ventricular activation patterns and conduction system pacing guidance.
• VDIAQ Acquisition Unit
• VDI DeepView

Products and services

• VDI UHF-ECG System CE-certified complete diagnostic platform combining VDIAQ Acquisition Unit hardware and VDI Vision software for ultra-high-frequency ECG signal analysis (up to 1,000 Hz), targeting electrophysiology departments performing pacemaker, CRT, and conduction system pacing procedures.
• VDI Vision Software platform providing real-time visualization of ventricular activation patterns, non-invasive conduction system pacing guidance, and UHF-ECG activation maps showing electrical dyssynchrony. Designed for electrophysiology cath lab workflow.
• VDIAQ Acquisition Unit ECG signal amplifier that captures ultra-high-frequency ECG signals beyond the standard ECG band (150-1000 Hz), designed for mechanical, electrical, and EMC safety.
• VDI DeepView Standalone software module for real-time post-processing and analysis of UHF-ECG data, providing enhanced activation maps and expanded parameters for spatial electrical activation of the ventricles; completes analyses in 2-5 seconds for 10-minute recordings.
• VDI Cart Dual-screen laptop configuration mounted on a single mobile cart (operator screen and mirrored physician screen), bundling the VDIAQ Acquisition Unit, VDI Vision Software, two monitors, laptop, ECG cables, optical cable, and accessories.
• VDI Laptop Pre-installed laptop configuration with VDI Vision software and accessories, designed for cath lab use with optional docking station for large-screen HDMI connection.
• VDI Portable Travel-friendly portable configurations including laptop bag, backpack, and protect case for transporting pre-installed laptop with VDI Vision software between rooms or facilities.

Quantifiable outcome

• Signals up to 1,000 Hz analyzed vs standard 100 Hz
• +3 more outcomes

Segments2 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability6 records

Feature5 records

Partnerships

Six partnerships are on record, tiered core.

• International Clinical Research Center (ICRC)coreStrategic or Co-development PartnerCollaborative research partner in licensing agreement for ECG-related patent. ICRC scientists contributed to development of ultra-high-frequency ECG innovation that was licensed to VDI Technologies.
• Third Faculty of Medicine at Charles UniversitycoreStrategic or Co-development PartnerAcademic partner in collaborative development of UHF-ECG technology. Contributed researchers to the patent licensing agreement alongside VDI Technologies.
• Institute of Scientific Instruments, Czech Academy of SciencescoreStrategic or Co-development PartnerOriginal research institution where VDI's UHF-ECG technology was first developed. Research team led by Pavel Jurak conducted first ultra-high-frequency ECG experiments in 2013.
• Cardion s.r.o.coreStrategic or Co-development PartnerCo-development partner in UHF-ECG patent licensing agreement and TAČR TREND project 'VDI UHF-ECG Mapping' (FW03010434). Contributed to development alongside VDI Technologies.
• St. Anne's University Hospital BrnocoreStrategic or Co-development PartnerClinical research partner in collaboration with Institute of Scientific Instruments. Pavel Leinveber's group conducted early UHF-ECG experiments. Later partnered in TAČR TREND project.
• University Hospital Kralovské Vinohrady, PraguecoreStrategic or Co-development PartnerClinical research partner under Karol Curila. EU structural grant supporting VDI Monitor hardware-software system design. Partner in TAČR TREND project for VDI UHF-ECG Mapping.

Scale indicators5 records

Recent moves7 records

Expansion highlights5 records

Emerging players

• AliveCor: AI-ECG company offering the KardiaMobile personal ECG and enterprise KardiaCloud platform. Shares ECG signal-processing and AI-based cardiac analysis technology with VDI but operates in the consumer/ambulatory segment rather than the procedural EP setting.
• iRhythm Technologies: Commercial-stage cardiac monitoring company with the Zio ambulatory ECG patch. Comparable as a digital cardiology diagnostics company leveraging algorithmic ECG analysis, though focused on ambulatory rhythm monitoring rather than procedural dyssynchrony imaging.
• HeartBeam: Compact 3-lead ECG device and AI-based cardiac diagnostic platform targeting remote and acute cardiac monitoring. Shares the ECG-signal-processing and AI-cardiology focus with VDI but addresses different use cases (outpatient monitoring vs. intraprocedural dyssynchrony imaging).
• Eko Health: Digital cardiac auscultation and ECG platform combining smart stethoscopes with AI-based cardiac analysis. Comparable as a digital cardiology hardware-plus-software company, though focused on primary care and ambulatory detection rather than procedural EP guidance.

Broad incumbents

• Biosense Webster (Johnson & Johnson): Subsidiary of J&J that sells the CARTO 3D electroanatomic mapping system, the dominant platform in electrophysiology labs. Directly comparable as it serves the same EP specialists performing ablation and device implants, where VDI's UHF-ECG adjunct would be used.
• Medtronic: Global leader in cardiac devices including pacemakers, CRT-Ds, and the CardioInsight electrocardiac mapping system. Overlaps with VDI on the CRT/CSP use cases and competes for hospital EP budgets.
• GE HealthCare: Sells hospital-grade ECG systems, cardiology imaging, and patient monitoring solutions used in hospitals worldwide. Comparable as an established provider of clinical ECG hardware and software platforms to hospitals, although its portfolio is far broader than VDI's dyssynchrony niche.
• Boston Scientific: Sells the RHYTHMIA HDx mapping system alongside a full EP device portfolio including CRT, conduction system pacing, and ablation tools. Directly targets the same hospital electrophysiology departments as VDI.
• Philips (Cardiology): Provides hospital ECG carts, cardiac monitoring, and intravascular ultrasound/imaging used in cardiology departments. Comparable as a hospital cardiology hardware-and-software vendor that competes for cath-lab and cardiac care budget allocations.
• Abbott: Major medtech incumbent with the EnSite Precision cardiac mapping system and a broad portfolio of EP devices (pacemakers, CRT-Ds, ablation catheters). Competes for the same cath-lab workflow and budget as VDI.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/channel/UC4I-TRQbiWfEdDvldAXg5ew
• Facebookfacebook.com/strikingly
• LinkedInlinkedin.com/company/uhfecg

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about VDI Technologies